查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587458

传染性呼吸道疾病诊断市场规模、份额和趋势分析：按产品、样本、应用、技术、最终用途、地区和细分市场预测，2025-2030 年

Infectious Respiratory Disease Diagnostics Market Size, Share & Trends Analysis By Product (Instruments, Services, Consumables), By Sample (Blood, NPS), By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

传染性呼吸道疾病诊断市场的成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球传染性呼吸道疾病诊断市场预计将达到 735.6 亿美元。

预计2025年至2030年该市场将以5.3%的复合年增长率成长。市场规模的下降主要是由于COVID-19检测的减少。然而，不受 COVID-19 影响的市场预计在预测期内将会成长。这种增长可归因于传染性呼吸道疾病的日益普及以及政府和非营利组织推出新的创新产品以满足不断增长的需求的倡议。例如，全球结核病研发投资达9.15亿美元，美国政府2020年用于结核病研究的支出约为4.01亿美元。

在预测期内，全球产业预计将受到结核病、呼吸道合胞病毒和流感等传染性呼吸道疾病盛行率上升的推动。根据联合国统计，肺炎每年影响约 420 万人。大公司正在开发创新技术并提高生产力，以满足对诊断感染疾病的诊断试剂和耗材不断增长的需求。例如，Opto Industries 推出了 3D 列印系统 InstaSwab，以解决因 COVID-19 大流行而导致的样本采集套件供不应求。这种棉籤由编织网格製成，比传统棉籤吸收和释放更多液体。该公司正在利用新技术改进其诊断产品，以实现针对特定目标的准确诊断结果。

2021年3月，Canon宣布开发数位X射线内建AEC援助。此 X 光影像感测器可实现 X 光相容的影像生成和即时检测。此外，2021 年 5 月，加州大学开发了一种超灵敏分子测试，利用晶片技术来识别 SARS-CoV-2 和甲型流感抗原的存在。此外，多家公司也提供同时诊断 RSV、流感和 COVID-19 呼吸道疾病的多重检测。 RT-PCR 检测被认为是病患诊断 COVID-19 的黄金标准。然而，与分子检测相关的高价格是抑制该市场的主要因素之一。

缺乏可比产品也是价格上涨的原因。每种分子诊断产品的价格根据其预期用途的不同而存在很大差异，进一步加剧了这个问题。公司正在采取新产品发布和合作伙伴关係等策略来提高传染性呼吸道疾病诊断产品的渗透率。例如，2021 年 8 月，Thermo Fisher Scientific Inc. 获得 EUA 向美国市场推出两款 COVID-19 诊断产品 TaqPath COVID-19 RNase P Combo Kit 和 TaqPath COVID-19 Fast PCR Combo Kit。

传染病诊断市场报告亮点

  • 消耗品领域占据市场主导地位，2024 年占最大收益占有率，达 64.3%。诊断设备的技术进步导致了更复杂的测试方法和对特殊耗材的需求。
  • 2024 年，COVID-19 细分市场在全球市场占据主导地位，占收益的 43.8%。 COVID-19 变体数量的增加、产品核可以及研发的增加推动了这一优势。
  • 北美传染性呼吸道疾病诊断市场在全球整体市场中占据主导地位，2024年占销售份额的41.85%。
  • 由于政府对诊断药物开发的关注和研发资金的增加，结核病预计在预测期内将呈现最快的复合年增长率。
  • 由于 IVD 产品渗透率的提高、可支配收入的增加以及低度开发国家的结核病患者病率较高，预计亚太地区将在预测期内经历最快的增长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章传染病诊断市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 传染病诊断市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章传染性呼吸道疾病诊断市场：产品评估与趋势分析

  • 细分仪表板
  • 传染病诊断市场：波动分析
  • 传染病诊断市场：展望
  • 2018-2030年市场规模、预测及趋势分析
  • 装置
    • 影像检查
    • 呼吸检测设备
    • 其他乐器
  • 消耗品
  • 服务

第五章 传染病诊断市场：样本估计与趋势分析

  • 细分仪表板
  • 传染病诊断市场：波动分析
  • 传染病诊断市场：展望
  • 2018-2030年市场规模、预测及趋势分析
  • 唾液
  • 鼻咽拭子
  • 前鼻区
  • 血
  • 其他的

第六章 传染病诊断市场：技术评估与趋势分析

  • 细分仪表板
  • 传染病诊断市场：波动分析
  • 传染病诊断市场：展望
  • 2018-2030年市场规模、预测及趋势分析
  • 免疫检测
  • 分子诊断
  • 微生物学
  • 其他技术

第七章传染性呼吸道疾病诊断市场：应用估算与趋势分析

  • 细分仪表板
  • 传染病诊断市场：波动分析
  • 传染病诊断市场：展望
  • 2018-2030年市场规模、预测及趋势分析
  • COVID-19
  • 流感
  • 呼吸道融合病毒（RSV）
  • 结核
  • 链球菌测试
  • 其他呼吸道疾病测试

第八章传染性呼吸道疾病诊断市场：最终用途估计与趋势分析

  • 细分仪表板
  • 传染病诊断市场：波动分析
  • 传染病诊断市场：展望
  • 2018-2030年市场规模、预测及趋势分析
  • 医院
  • 诊断实验室
  • 製药和生物技术公司
  • 医生办公室
  • 其他最终用户

第九章传染性呼吸道疾病诊断市场：区域估计与趋势分析

  • 区域仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争格局

  • 市场参与企业分类
  • 主要市场参与企业的最新趋势和影响分析
  • 2024 年企业市场占有率分析
  • 主要企业简介
    • ABBOTT
    • F. Hoffmann-La Roche Ltd
    • THERMO FISHER SCIENTIFIC, INC.
    • KONINKLIJKE PHILIPS NV
    • BIOMERIEUX SA
    • BIO-RAD LABORATORIES, INC.
    • QUIDEL CORPORATION
    • CEPHEID
    • QIAGEN
    • SIEMENS HEALTHCARE GMBH
Product Code: GVR-4-68039-976-4

Infectious Respiratory Disease Diagnostics Market Growth & Trends:

The global infectious respiratory disease diagnostics market size is anticipated to reach USD 73.56 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 5.3% from 2025 to 2030. The decline in market size is majorly attributed to the decline in COVID-19 testing. However, the market without the impact of COVID-19 is expected to grow over the forecast years. The growth can be attributed to an increase in the prevalence of infectious respiratory diseases and initiatives taken by governments & nonprofit organizations to introduce novel & innovative products to address the increasing demand. For instance, the global investment in tuberculosis R&D reached USD 915 million, and around USD 401 million was spent by the U.S. government on TB research in 2020.

During the forecast period, the global industry is expected to be driven by the rising incidence of infectious respiratory disorders, such as tuberculosis, RSV, and influenza. According to the UN, pneumonia affects around 4.2 million people every year. Key players are developing innovative techniques to improve production for meeting the growing demand in diagnostics and consumables for the diagnosis of infectious diseases. For instance, OPT Industries Inc. has introduced InstaSwab by utilizing the 3D printing system to address supply shortages of sample collection kits due to the COVID-19 pandemic. These swabs are made of woven lattices to absorb and release more fluid than conventional swabs. Companies are advancing their diagnosis products by using new techniques to gain target-specific and accurate results.

Canon Inc. announced the development of a built-in AEC assistance for digital X-rays in March 2021. The X-ray image sensor enables users to perform picture production and real-time detection of images corresponding to emitted X-rays. Furthermore, in May 2021, the University of California developed an ultrasensitive molecular test to identify the presence of SARS-CoV-2 and influenza A antigens using chip technology. In addition, companies are also launching multiplex tests for the simultaneous diagnosis of RSV, influenza, and COVID-19 respiratory diseases. RT-PCR tests are considered the gold standard for the diagnosis of COVID-19 in patients. However, high prices associated with molecular tests are one of the major factors impeding this market.

The lack of comparable products is another reason for hiked prices. This problem is further compounded by the significant variations in prices for different applications of each molecular diagnostic product. Companies are adopting strategies, such as new product launches and partnerships, to increase the penetration of infectious respiratory disease diagnostics products. For instance, in August 2021, Thermo Fisher Scientific Inc. received EUA for the introduction of two COVID-19 diagnostic products, TaqPath COVID-19 RNase P Combo Kit and TaqPath COVID-19 Fast PCR Combo Kit, in the U.S. market.

Infectious Respiratory Disease Diagnostics Market Report Highlights:

  • The consumables segment dominated the market and accounted for the largest revenue share of 64.3% in 2024. Technological advancements in diagnostic devices have resulted in more sophisticated testing methods, necessitating specialized consumables.
  • The COVID-19 segment dominated the global market in 2024, accounting for 43.8% of the revenue. Increased COVID-19 variants, product approvals, and heightened research and development efforts drove this dominance.
  • North America infectious respiratory disease diagnostics market dominated the overall global market and accounted for 41.85% of revenue share in 2024.
  • Tuberculosis is expected to exhibit the fastest CAGR over the forecast period owing to increasing government focus and R&D funding for the development of diagnostics
  • Asia Pacific is expected to experience the fastest growth over the forecast period owing to an increase in penetration of IVD products, rise in disposable income, and high prevalence of tuberculosis in underdeveloped countries

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Sample
    • 1.2.3. Product
    • 1.2.4. End Use
    • 1.2.5. Application
    • 1.2.6. Regional Scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Infectious Respiratory Disease Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High Prevalence Of Infectious Respiratory Diseases Globally
      • 3.2.1.2. Technological Advancement In Respiratory Disease Testing
      • 3.2.1.3. Rising R&D Investments In Respiratory Disease Testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Prices Of Diagnostic Products
      • 3.2.2.2. Presence Of Ambiguous Regulatory Framework
  • 3.3. Infectious Respiratory Disease Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Infectious Respiratory Disease Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Infectious Respiratory Disease Diagnostics Market: Product Movement Analysis
  • 4.3. Infectious Respiratory Disease Diagnostics Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Instruments
    • 4.5.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Imaging Tests
      • 4.5.2.1. Imaging Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Respiratory Measurement Devices
      • 4.5.3.1. Respiratory Measurement Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Other Instruments
      • 4.5.4.1. Other Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Consumables
    • 4.6.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Services
    • 4.7.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Infectious Respiratory Disease Diagnostics Market: Sample Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Infectious Respiratory Disease Diagnostics Market: Sample Movement Analysis
  • 5.3. Infectious Respiratory Disease Diagnostics Market by Sample Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Saliva
    • 5.5.1. Saliva Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Nasopharyngeal Swabs
    • 5.6.1. Nasopharyngeal Swabs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Anterior Nasal Region
    • 5.7.1. Anterior Nasal Region Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Blood
    • 5.8.1. Blood Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Infectious Respiratory Disease Diagnostics Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Infectious Respiratory Disease Diagnostics Market: Technology Movement Analysis
  • 6.3. Infectious Respiratory Disease Diagnostics Market by Technology Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Immunoassay
    • 6.5.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Molecular Diagnostics
    • 6.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Microbiology
    • 6.7.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Other Technologies
    • 6.8.1. Other Technologies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Infectious Respiratory Disease Diagnostics Market: Application Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Infectious Respiratory Disease Diagnostics Market: Application Movement Analysis
  • 7.3. Infectious Respiratory Disease Diagnostics Market by Application Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. COVID-19
    • 7.5.1. COVID-19 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Influenza
    • 7.6.1. Influenza Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Respiratory Syncytial Virus
    • 7.7.1. Respiratory Syncytial Virus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Tuberculosis
    • 7.8.1. Tuberculosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Streptococcus Testing
    • 7.9.1. Streptococcus Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.10. Other Respiratory Disease Testing
    • 7.10.1. Other Respiratory Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Infectious Respiratory Disease Diagnostics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Infectious Respiratory Disease Diagnostics Market: End Use Movement Analysis
  • 8.3. Infectious Respiratory Disease Diagnostics Market by End Use Outlook (USD Million)
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.5. Hospitals
    • 8.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Diagnostic Laboratories
    • 8.6.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Pharmaceutical & Biotechnology Companies
    • 8.7.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Physician Offices
    • 8.8.1. Physician Offices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9. Other End-Users
    • 8.9.1. Other End-Users Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Infectious Respiratory Disease Diagnostics Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Dashboard
  • 9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.3. North America
    • 9.3.1. U.S.
      • 9.3.1.1. Key country dynamics
      • 9.3.1.2. Regulatory framework/ reimbursement structure
      • 9.3.1.3. Competitive scenario
      • 9.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.3.2. Canada
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework/ reimbursement structure
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.3.3. Mexico
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework/ reimbursement structure
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework/ reimbursement structure
      • 9.4.1.3. Competitive scenario
      • 9.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework/ reimbursement structure
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework/ reimbursement structure
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework/ reimbursement structure
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework/ reimbursement structure
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.6. Norway
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework/ reimbursement structure
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework/ reimbursement structure
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.4.8. Denmark
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Regulatory framework/ reimbursement structure
      • 9.4.8.3. Competitive scenario
      • 9.4.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.3. India
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.4. Australia
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework/ reimbursement structure
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework/ reimbursement structure
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework/ reimbursement structure
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Recent Developments & Impact Analysis by Key Market Participants
  • 10.3. Company Market Share Analysis, 2024
  • 10.4. Key Company Profiles
    • 10.4.1. ABBOTT
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. F. Hoffmann - La Roche Ltd
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. THERMO FISHER SCIENTIFIC, INC.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. KONINKLIJKE PHILIPS N.V.
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. BIOMERIEUX SA
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. BIO-RAD LABORATORIES, INC.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. QUIDEL CORPORATION
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. CEPHEID
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. QIAGEN
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. SIEMENS HEALTHCARE GMBH
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 4. Global infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 5. Global infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 6. Global infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 7. Global infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 8. North America infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 9. North America infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 10. North America infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 11. North America infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 12. North America infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 13. U.S. infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 14. U.S. infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 15. U.S. infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 16. U.S. infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 17. U.S. infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 18. Canada infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 19. Canada infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 20. Canada infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 21. Canada infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 22. Canada infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 23. Mexico infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 24. Mexico infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 25. Mexico infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 26. Mexico infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 27. Mexico infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 28. Europe infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 29. Europe infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 30. Europe infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 31. Europe infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 32. Europe infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 33. UK infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 34. UK infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 35. UK infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 36. UK infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 37. UK infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 38. Germany infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 39. Germany infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 40. Germany infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 41. Germany infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 42. Germany infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 43. France infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 44. France infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 45. France infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 46. France infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 47. France infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 48. Italy infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 49. Italy infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 50. Italy infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 51. Italy infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 52. Italy infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 53. Spain infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 54. Spain infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 55. Spain infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 56. Spain infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 57. Spain infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 58. Denmark infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 59. Denmark infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 60. Denmark infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 61. Denmark infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 62. Denmark infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 63. Sweden infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 64. Sweden infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 65. Sweden infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 66. Sweden infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 67. Sweden infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 68. Norway infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 69. Norway infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 70. Norway infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 71. Norway infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 72. Norway infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 73. Asia Pacific infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 74. Asia Pacific infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 75. Asia Pacific infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 76. Asia Pacific infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 77. Asia Pacific infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 78. Japan infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 79. Japan infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 80. Japan infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 81. Japan infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 82. Japan infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 83. China infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 84. China infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 85. China infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 86. China infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 87. China infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 88. India infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 89. India infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 90. India infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 91. India infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 92. India infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 93. Australia infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 94. Australia infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 95. Australia infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 96. Australia infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 97. Australia infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 98. South Korea infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 99. South Korea infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 100. South Korea infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 101. South Korea infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 102. South Korea infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 103. Thailand infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 104. Thailand infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 105. Thailand infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 106. Thailand infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 107. Thailand infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 108. Latin America infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 109. Latin America infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 110. Latin America infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 111. Latin America infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 112. Latin America infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 113. Brazil infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 114. Brazil infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 115. Brazil infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 116. Brazil infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 117. Brazil infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 118. Argentina infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 119. Argentina infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 120. Argentina infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 121. Argentina infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 122. Argentina infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 123. Middle East & Africa infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 124. Middle East & Africa infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 125. Middle East & Africa infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 126. Middle East & Africa infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 127. Middle East & Africa infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 128. South Africa infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 129. South Africa infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 130. South Africa infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 131. South Africa infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 132. South Africa infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 133. Saudi Arabia infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 134. Saudi Arabia infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 135. Saudi Arabia infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 136. Saudi Arabia infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 137. Saudi Arabia infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 138. UAE infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 139. UAE infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 140. UAE infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 141. UAE infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 142. UAE infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)
  • Table 143. Kuwait infectious respiratory disease diagnostics market, by Product, 2018 - 2030 (USD Million)
  • Table 144. Kuwait infectious respiratory disease diagnostics market, by Application, 2018 - 2030 (USD Million)
  • Table 145. Kuwait infectious respiratory disease diagnostics market, by Technology, 2018 - 2030 (USD Million)
  • Table 146. Kuwait infectious respiratory disease diagnostics market, by Sample, 2018 - 2030 (USD Million)
  • Table 147. Kuwait infectious respiratory disease diagnostics market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Infectious respiratory disease diagnostics market segmentation
  • Fig. 7 Market driver analysis (current & future impact)
  • Fig. 8 Market restraint analysis (current & future impact)
  • Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 10 Porter's five forces analysis
  • Fig. 11 Infectious respiratory disease diagnostics market, Product outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 12 Infectious respiratory disease diagnostics market, Sample outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 13 Infectious respiratory disease diagnostics market, Technology outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 14 Infectious respiratory disease diagnostics market, Application outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 15 Infectious respiratory disease diagnostics market, End Use outlook key takeaways 2024 & 2030 (USD Million)
  • Fig. 16 Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Imaging Tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Respiratory Measurement Devices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Other Instruments market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Consumables market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Services market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Saliva market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Nasopharyngeal Swabs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Anterior Nasal Region market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Blood market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Immunoassay market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Molecular Diagnostics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Microbiology market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Other Technologies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 COVID-19 market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Influenza market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Respiratory Syncytial Virus market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Tuberculosis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Streptococcus Testing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Other Respiratory Disease Testing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Diagnostic Laboratories market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Physician Offices market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Other End users market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 North America infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Canada infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Mexico infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Europe infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 UK infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Germany infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 France infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Norway infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Asia Pacific infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 China infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Japan infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 India infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Argentina infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Middle East and Africa infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 South Africa infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Saudi Arabia infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 UAE infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Kuwait infectious respiratory disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 List of key emerging company's/Allergen disruptors/innovators